{
  "pmid": "34940805",
  "uid": "34940805",
  "title": "Metformin-A Thought-provoking Addition to Anticancer Therapies-Reply.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Tsakiridis",
      "fore_name": "Theodoros",
      "initials": "T",
      "name": "Theodoros Tsakiridis",
      "affiliations": [
        "Department of Oncology, McMaster University, Hamilton, Ontario, Canada."
      ]
    },
    {
      "last_name": "Pond",
      "fore_name": "Gregory R",
      "initials": "GR",
      "name": "Gregory R Pond",
      "affiliations": [
        "Department of Oncology, McMaster University, Hamilton, Ontario, Canada.",
        "Ontario Clinical Oncology Group, McMaster University, Hamilton, Ontario, Canada."
      ]
    },
    {
      "last_name": "Wright",
      "fore_name": "James",
      "initials": "J",
      "name": "James Wright",
      "affiliations": [
        "Department of Oncology, McMaster University, Hamilton, Ontario, Canada.",
        "Ontario Clinical Oncology Group, McMaster University, Hamilton, Ontario, Canada."
      ]
    }
  ],
  "journal": {
    "title": "JAMA oncology",
    "iso_abbreviation": "JAMA Oncol",
    "issn": "2374-2445",
    "issn_type": "Electronic",
    "volume": "8",
    "issue": "2",
    "pub_year": "2022",
    "pub_month": "Feb",
    "pub_day": "01"
  },
  "start_page": "303",
  "end_page": "304",
  "pages": "303-304",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Antineoplastic Combined Chemotherapy Protocols",
    "Drug Resistance, Neoplasm",
    "Humans",
    "Metformin"
  ],
  "article_ids": {
    "pubmed": "34940805",
    "doi": "10.1001/jamaoncol.2021.6729",
    "pii": "2787234"
  },
  "doi": "10.1001/jamaoncol.2021.6729",
  "dates": {
    "completed": "2022-03-14",
    "revised": "2022-04-26"
  },
  "chemicals": [
    "Metformin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:52:52.293450",
    "pmid": "34940805"
  }
}